Minocycline inhibits the expression of CD68, cell surface markers of M1 polarized microglia, and inflammatory cytokines (IL-1β and TNF-a) both in vitro and in an animal model of amyotrophic lateral sclerosis. The gene discussed is TNF; the disease is amyotrophic lateral sclerosis.